Filed: 5/15/2023ACC: 0001420506-23-001082
📋 What this filing means
IKARIAN CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 97 equity positions with a total reported market value of $440.74M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
97
Positions
$440.74M
Total AUM (reported)
33.66M
Total Shares
Allocation by class
COM$338.72M76.9%
COM NEW$35.78M8.1%
CL A$16.42M3.7%
SPONSORED ADS$13.59M3.1%
COM PAR $.01$11.68M2.6%
S&P BIOTECH$7.62M1.7%
SHS$4.77M1.1%
Portfolio Concentration
Top 3$106.40M24.1%
4–10$104.54M23.7%
11–25$125.30M28.4%
Rest$104.51M23.7%
Top 3 weight
24.1%
Top 10 weight
47.9%
Voting Authority Distribution
Total shares with voting rights: 33.66M
Sole
Full voting authority
33.66M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole97
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings97
Rows:
SAREPTA THERAPEUTICS INC
SOLEShares485.02K
TypeSH
Market value$66.85M
15.17%
Sole
485.02K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares380K
TypeSH
Market value$20.58M
4.67%
Sole
380K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares1.14M
TypeSH
Market value$18.97M
4.30%
Sole
1.14M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares300K
TypeSH
Market value$18.50M
4.20%
Sole
300K
Shared
0.00
None
0.00
BIOMEA FUSION INC
SOLEShares541.98K
TypeSH
Market value$16.81M
3.81%
Sole
541.98K
Shared
0.00
None
0.00
REATA PHARMACEUTICALS INC
SOLEShares180.56K
TypeSH
Market value$16.42M
3.72%
Sole
180.56K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares934.70K
TypeSH
Market value$14.50M
3.29%
Sole
934.70K
Shared
0.00
None
0.00
PROMETHEUS BIOSCIENCES INC
SOLEShares125.93K
TypeSH
Market value$13.51M
3.07%
Sole
125.93K
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares1.62M
TypeSH
Market value$13.12M
2.98%
Sole
1.62M
Shared
0.00
None
0.00
INSMED INC
SOLEShares685K
TypeSH
Market value$11.68M
2.65%
Sole
685K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares869.39K
TypeSH
Market value$11.56M
2.62%
Sole
869.39K
Shared
0.00
None
0.00
ALTIMMUNE INC
SOLEShares2.65M
TypeSH
Market value$11.20M
2.54%
Sole
2.65M
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares100K
TypeSH
Market value$10.64M
2.41%
Sole
100K
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares259.27K
TypeSH
Market value$9.76M
2.21%
Sole
259.27K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares422.80K
TypeSH
Market value$9.72M
2.21%
Sole
422.80K
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS PLC
SOLEShares407.11K
TypeSH
Market value$8.66M
1.96%
Sole
407.11K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares721.34K
TypeSH
Market value$8.54M
1.94%
Sole
721.34K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares225K
TypeSH
Market value$8.43M
1.91%
Sole
225K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares216.06K
TypeSH
Market value$7.77M
1.76%
Sole
216.06K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares100K
TypeSH
Market value$7.62M
1.73%
Sole
100K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares100K
TypeSH
Market value$6.60M
1.50%
Sole
100K
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares283.46K
TypeSH
Market value$6.56M
1.49%
Sole
283.46K
Shared
0.00
None
0.00
BELLUS HEALTH INC NEW
SOLEShares885.33K
TypeSH
Market value$6.37M
1.45%
Sole
885.33K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares447.53K
TypeSH
Market value$6.11M
1.39%
Sole
447.53K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares160.49K
TypeSH
Market value$5.74M
1.30%
Sole
160.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SAREPTA THERAPEUTICS INCSOLE | COM | 485.02K | SH | $66.85M 15.17% | 485.02K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 380K | SH | $20.58M 4.67% | 380K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 1.14M | SH | $18.97M 4.30% | 1.14M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 300K | SH | $18.50M 4.20% | 300K | 0.00 | 0.00 |
BIOMEA FUSION INCSOLE | COM | 541.98K | SH | $16.81M 3.81% | 541.98K | 0.00 | 0.00 |
REATA PHARMACEUTICALS INCSOLE | CL A | 180.56K | SH | $16.42M 3.72% | 180.56K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 934.70K | SH | $14.50M 3.29% | 934.70K | 0.00 | 0.00 |
PROMETHEUS BIOSCIENCES INCSOLE | COM | 125.93K | SH | $13.51M 3.07% | 125.93K | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 1.62M | SH | $13.12M 2.98% | 1.62M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 685K | SH | $11.68M 2.65% | 685K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 869.39K | SH | $11.56M 2.62% | 869.39K | 0.00 | 0.00 |
ALTIMMUNE INCSOLE | COM NEW | 2.65M | SH | $11.20M 2.54% | 2.65M | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 100K | SH | $10.64M 2.41% | 100K | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | COM | 259.27K | SH | $9.76M 2.21% | 259.27K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 422.80K | SH | $9.72M 2.21% | 422.80K | 0.00 | 0.00 |
BICYCLE THERAPEUTICS PLCSOLE | SPONSORED ADS | 407.11K | SH | $8.66M 1.96% | 407.11K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 721.34K | SH | $8.54M 1.94% | 721.34K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 225K | SH | $8.43M 1.91% | 225K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 216.06K | SH | $7.77M 1.76% | 216.06K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 100K | SH | $7.62M 1.73% | 100K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 100K | SH | $6.60M 1.50% | 100K | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | COM | 283.46K | SH | $6.56M 1.49% | 283.46K | 0.00 | 0.00 |
BELLUS HEALTH INC NEWSOLE | COM NEW | 885.33K | SH | $6.37M 1.45% | 885.33K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 447.53K | SH | $6.11M 1.39% | 447.53K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 160.49K | SH | $5.74M 1.30% | 160.49K | 0.00 | 0.00 |
Page 1 of 4